Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
123.03
-2.86 (-2.27%)
Streaming Delayed Price
Updated: 1:26 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
87
88
Next >
Jim Cramer Lists 6 Conditions For Market Selloff To End Amid 'Discouraging' Inflation Data
February 21, 2023
Prominent market commentator Jim Cramer on Tuesday suggested a six-point checklist of events that must happen before declaring an end to the market sell-off.
Via
Benzinga
Merck's COVID-19 Treatment Fails To Prevent Infection In Household Exposure
February 21, 2023
Via
Benzinga
Merck to Present New Data for Sotatercept and MK-0616 at ACC.23/WCC, Demonstrating Significant Progress in Advancing Its Innovative Cardiovascular Pipeline
February 21, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO™ (molnupiravir) for Post-exposure Prophylaxis for Prevention of COVID-19
February 21, 2023
From
Merck & Co., Inc.
Via
Business Wire
Why Shares of Organon Fell 15% Thursday
February 16, 2023
The company reported fourth-quarter and year-end financials.
Via
The Motley Fool
2 Ultra-Safe Dividend Stocks to Buy Right Now
February 16, 2023
These two dividend stocks are top buys for investors concerned about an economic slowdown.
Via
The Motley Fool
3 Large-Cap Biotech Stocks to Hold for the Long Haul
February 19, 2023
These three large-cap biotech stocks survived or went up in 2022 when most of the market went down by double digits.
Via
InvestorPlace
2022 Annual Review
February 18, 2023
In this annual review, I look at my dividend portfolio's performance as measured by dividend income, dividend increases, annualized returns, and rate of return. I also share some highlights of the past...
Via
Talk Markets
I ‘Tricked’ ChatGPT Into Picking Stocks to Buy. Here’s What It Said.
February 17, 2023
We asked ChatGPT to name various types of stocks to buy. Can the latest artificial intelligence craze get things right?
Via
InvestorPlace
Should Income Investors Buy This Dow Jones Stock?
February 17, 2023
This drugmaker boasts an impressive product portfolio and pipeline.
Via
The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
February 10, 2023
Via
Benzinga
U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for Merck’s PREVYMIS™ for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk
February 17, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Says Keytruda/Chemo Combo Improved Overall Survival Compared To Chemo Alone In Gastric Cancer Settings
February 16, 2023
Via
Benzinga
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
February 16, 2023
Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024.
Via
MarketBeat
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone in Patients With HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Regardless of PD-L1 Expression
February 16, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck and AstraZeneca Present Final Results of Key Secondary Overall Survival Endpoint From Phase 3 PROpel Trial at 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium
February 16, 2023
From
Merck & Co., Inc.
Via
Business Wire
2 Market-Beating Dividend Stocks to Buy With $500
February 16, 2023
These two leading healthcare stocks have been rewarding shareholders with dividends for a while.
Via
The Motley Fool
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
February 15, 2023
Cannabis companies of all sizes are struggling to increase their profit margins and to make that happen, they're implementing different strategies. Lowering prices and premiumizing products are among...
Via
Benzinga
Robinhood, Merck And 2 Other Stocks Insiders Are Selling
February 15, 2023
The Nasdaq closed higher by around 0.6% on Tuesday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 14, 2023
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Via
Benzinga
BioXcel Therapeutics Unveils Complete Data From BXCL701/Keytruda Combo Study In Prostate Cancer Subtype
February 14, 2023
Via
Benzinga
Acurx is Setting a High Bar for New Treatments in C. diff
February 14, 2023
A New Gold Standard for C. diff Therapy Could be in the Offing; Next Data Release Expected in 2Q23
Via
Benzinga
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers
February 13, 2023
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends.
Via
Talk Markets
New 52-Week Highs In 2023
February 13, 2023
20% of stocks in the large-cap Russell 1,000 have made 52-week highs at some point so far in 2023.
Via
Talk Markets
Stellar Opportunity For Merck At Upcoming Data Presentation, Analyst Says While Boosting Price Target
February 13, 2023
Via
Benzinga
IMV Stock Falls After Interim Data From Lead Candidate In Blood Cancer Subtype
February 13, 2023
Via
Benzinga
Fox, MGM Resorts And 3 Other Stocks Insiders Are Selling
February 13, 2023
The Nasdaq closed lower on Friday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
MarketBeat Week in Review – 2/6 - 2/10
February 11, 2023
Markets are closed the week looking for direction as investors believe a soft landing is not possible and higher interest rates are likely
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
Interest Rates
Aligos Reprioritizes Pipeline With Focus On NASH, COVID Programs, Cuts Another 10% Of Its Workforce
February 09, 2023
Via
Benzinga
Amazon, Tesla And 2 Other Stocks Insiders Are Selling
February 09, 2023
The Nasdaq dropped by around 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
87
88
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.